Bone mineral density and risk of osteoporotic fracture in patients with psoriatic arthritis
Authors:
Studýnková Tomasová Jana
Authors place of work:
Revmatologická klinika 1. LF UK a Revmatologický ústav, Praha
Published in the journal:
Clinical Osteology 2022; 27(1): 17-25
Category:
Přehledové články
Summary
Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disease that affects especially peripheral and axial joints. PsA is a heterogeneous disease frequently associated with psoriasis and several other comorbidities, including osteoporosis. Osteoporosis (OP) is a chronic systemic skeletal disease characterized by progressive bone loss, disruption of bone microarchitecture, and increased risk of fragility fracture. Psoriatic arthritis and psoriasis are associated with reduced BMD and are at greater risk of developing osteoporosis and osteoporotic fracture which could be the reason of worsening of the prognosis in patients with psoriatic arthritis.
Keywords:
Psoriatic arthritis – densitometry – osteoporosis – bone mineral density – osteoporotic fractures
Zdroje
1. Taylor W, Gladman D, Helliwell P et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international s tudy. A rthritis R heumatol 2 006; 5 4(8): 2 665–2673. Dostupné z DOI: <http://dx.doi.org/10.1002/art.21972>.
2. Gladman DD, Antoni C, Mease P et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2 005; 6 4(Suppl 2 ): i i14–17. Dostupné z DOI: < http://dx.doi. org/10.1136/ard.2004.032482>.
3. Kaine J, Song X, Kim G et al. Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using U.S. Administrative Claims Data. J Manag Care Spec Pharm 2019; 25(1): 122–132. Dostupné z DOI: <http://dx.doi.org/10.18553/jmcp.2018.17421>.
4. Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2 010; 3 4(3): J 314–J321. Dostupné z DOI: < http://dx.doi.org/ 10.1016/j.jaut.2009.12.001>.
5. Lorentzon M, Cummings SR. Osteoporosis: the evolution of a diagnosis. J Intern Med 2015; 277(6): 650–661. Dostupné z DOI: <http://dx.doi.org/10.1111/joim.12369>.
6. Chen TL, Lu JW, Huang YW et al. Bone Mineral Density, Osteoporosis, and Fracture Risk in Adult Patients with Psoriasis or Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Observational Studies. J Clin Med 2020; 9(11): 3712. Dostupné z DOI: <http://dx.doi.org/10.3390/jcm9113712>.
7. Simon D, Kleyer A, Bayat S et al. Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients. Arthritis Res Ther 2019 3; 21(1): 162. Dostupné z DOI: <http://dx.doi.org/10.1186/s13075–019–1938–3>.
8. Paine A, Ritchlin Ch. Altered bone remodeling in psoriatic disease: New insights and future directions. Calcif Tissue Int 2018; 102(5): 559–574. Dostupné z DOI: <http://dx.doi.org/10.1007/s00223–017–0380–2>.
9. Keller J, Kang J, Lin H. Association between osteoporosis and psoriasis: results from the Longitudinal Health Insurance Database in Taiwan. Osteoporos Int 2013; 24(6): 1835–1841. Dostupné z DOI: <http://dx.doi.org/10.1007/s00198–012–2185–5>.
10. Pedreira PG, Pinheiro MM, Szejnfeld VL. Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis. Arthritis Res Ther 2011; 13(1): R16. Dostupné z DOI: <http://dx.doi.org/10.1186/ar3240>.
11. Dreiher J, Weitzman D, Cohen A. Psoriasis and osteoporosis: a sex-specific association? J Invest Dermatol. 2009; 129(7): 1643– 1649. Dostupné z DOI: <http://dx.doi.org/10.1038/jid.2008.432>.
12. Kocijan R, Englbrecht M, Haschka J et al. Quantitative and qualitative changes of bone in psoriasis and psoriatic arthritis patients. J Bone Miner Res 2015; 30(10): 1775–1783. Dostupné z DOI: <http://dx.doi.org/10.1002/jbmr.2521>.
13. Goldring SR. Differential mechanisms of de-regulated bone formation in rheumatoid arthritis and spondyloarthritis. Rheumatology ( Oxford) 2 016; 5 5(1): 5 6–60. Dostupné z DOI: < http://dx.doi. org/10.1093/rheumatology/kev283>.
14. Chandran S, Aldei A, Johnson SR et al. Prevalence and risk factors of low bone mineral density in psoriatic arthritis: A systematic review. Semin Arthritis Rheum 2016; 4 6(2): 174–182. Dostupné z DOI: <http://dx.doi.org/10.1016/j.semarthrit.2016.05.005>.
15. Ogdie A, Harter L, Shin D et al. The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study. Ann Rheum Dis 2017; 76(5): 882–885. Dostupné z DOI: <http://dx.doi.org/10.1136/annrheumdis-2016–210441>.
16. Reddy SM, Anandarajah AP, Fisher MC et al. Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry. J Rheumatol 2 010; 3 7(12): 2 566–2572. Dostupné z DOI: <http://dx.doi.org/10.3899/jrheum.100483>.
17. Modalsli EH, Asvold BO, Romundstad PR et al. Psoriasis, fracture risk and bone mineral density: the HUNT Study, Norway. Br J Dermatol 2017; 176(5): 1162–1169. Dostupné z DOI: <http://dx.doi.org/10.1111/bjd.15123>.
18. Frediani B, Allegri A, Falsetti et al. Bone mineral density in patients with psoriatic arthritis. J Reumatol 2001; 28(1): 138‐143.
19. Nolla JM, Fiter J, Rozadilla A et al: Bone mineral density in patients with peripheral psoriatic arthritis. Rev Rhum Engl 1999; 66(10): 457‐461.
20. Hofbauer LC, Schoppet M, Christ M et al.Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levelsin psoriatic arthritis. Rheumatology (Oxford) 2006; 45(10): 1218–22. Dostupné z DOI: <http://dx.doi.org/10.1093/rheumatology/kel108>.
21. Grazio S, Cvijetić S, Vlak T et al. Osteoporosis in psoriatic arthritis: is there any? Wien Klin Wochenschr 2011; 123(23–24): 743–750. Dostupné z DOI: <http://dx.doi.org/10.1007/s00508–011–0095–8>.
22. Borman P, Babaoğlu S, Gur G et al. Bone mineral density and bone turnover in patients with psoriatic arthritis. Clin Rheumatol 2008; 27(4): 4 43–447. Dostupné z DOI: <http://dx.doi.org/10.1007/s10067–007–0725–8>.
23. Riesco M, Manzano F, Font P et al. Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures. Clin R heumatol 2 013; 3 2(12):1799–1804. Dostupné z DOI: < http:// dx.doi.org/10.1007/s10067–013–2322–3>.
24. Attia EA, Khafagy A, Abdel-Raheem S et al. Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity. Int J Dermatol 2011; 50(1): 30–35. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365–4632.2010.04600.x>.
25. Xia J, Xie SY, Liu KQ et al. Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study. Ann Rheum Dis 2020; 79(11): 1460–1467. Dostupné z DOI: <http://dx.doi.org/10.1136/annrheumdis-2020–217892>.
26. Busquets N, Vaquero CG, Moreno JR et al. Bone mineral density status and frequency of osteoporosis and clinical fractures in 155 patients with psoriatic arthritis followed in a university hospital. Reumatol Clin 2014; 10(2): 89–93. Dostupné z DOI: <http://dx.doi.org/10.1016/j.reuma.2013.07.006>.
27. Kocijan R, Finzel S, Englbrecht M et al. Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity. Ann Rheum Dis 2014; 73(11): 2022–2028. Dostupné z DOI: <http://dx.doi.org/10.1136/annrheumdis-2013–203791>.
28. van der Weijden MA, van der Horst-Bruinsma IE, van Denderen JC et al. High frequency of vertebral fractures in early spondylarthropathies. Osteoporos Int 2012; 23(6): 1683–1690. Dostupné z DOI: <http://dx.doi.org/10.1007/s00198–011–1766-z>.
29. Lo Giudice LF, Scolnik M, Pierini FS et al. Fragility fractures in psoriatic arthritis patients: a matched retrospective cohort study. Clin Rheumatol 2020; 39(12): 3685–3691. Dostupné z DOI: <http://dx.doi.org/10.1007/s10067–020–05074–8>.
30. Kathuria P, Gordon KB, Silverberg JI. Association of psoriasis and psoriatic arthritis with osteoporosis and pathological fractures. J Am Acad Dermatol 2017; 76(6): 1045–1053. e3. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaad.2016.11.046>.
31. Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 2008; 473(2): 139–146. Dostupné z DOI: <http://dx.doi.org/10.1016/j.abb.2008.03.018>.
32. D’Epiro S, Marocco C, Salvi M et al. Psoriasis and bone mineral density: implications for long-term patients. J Dermatol 2014; 41(9): 783–787. Dostupné z DOI: <http://dx.doi.org/10.1111/1346–8138.12546>.
33. Grisar J, Bernecker PM, Aringer M et al. Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. J Rheumatol 2002; 29(7): 1430–1436.
Štítky
Biochemie Dětská gynekologie Dětská radiologie Dětská revmatologie Endokrinologie Gynekologie a porodnictví Interní lékařství Ortopedie Praktické lékařství pro dospělé Radiodiagnostika Rehabilitační a fyzikální medicína Revmatologie Traumatologie OsteologieČlánek vyšel v časopise
Clinical Osteology
2022 Číslo 1
Nejčtenější v tomto čísle
- Chondroblastóm femuru – benígny nádor s potenciálne vážnymi následkami: kazuistika
- Casus socialis: sociálny či medicínsky problém? Kazuistika
- Změny kostní denzity a riziko osteoporotických fraktur u pacientů s psoriatickou artritidou
- A need for predictive and personalized approach in osteoporosis treatment: individual treatment plan